Open-Label Extension Studies: Do They Provide Meaningful Information on the Safety of New Drugs?

Author： Day Richard O.   Williams Kenneth M.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.30, Iss.2, 2007-01, pp. : 93-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Why do Americans pay more for drugs?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 601, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Is the UK government delaying approval for new cancer drugs?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 649, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Open-Label Extension Studies: Interpretation and Statistical Issues

By Weatherall Mark   Burgess Carl   Taylor William  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 2, 2007-01 ,pp. : 115-120

Adis International

Access to resources Recommend Favorite

Willingness-to-pay a better measure to value drugs?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 609, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Awakenings and Awareness Recovery in Disorders of Consciousness: Is There a Role for Drugs?

By Pistoia Francesca   Mura Elisa  

CNS Drugs, Vol. 24, Iss. 8, 2010-08 ,pp. : 625-638

Adis International

Access to resources Recommend Favorite